Beyond The Printed Page

  1. Pfizer’s Head Of R&D On The Importance Of Being Hyper Focused
    8/12/2019

    Pfizer’s top scientist, Mikael Dolsten, M.D., Ph.D., talks about being hyper focused during company’s R&D turnaround amongst CEO turnover, company integrations and M&A.

  2. How Tony Robbins Became An Investor In Celularity
    7/22/2019

    Robert Hariri, M.D., Ph.D., discusses how he became friends with life coach Tony Robbins, and why Robbins decided to invest in his company.

  3. Support For Women-Led Early-Stage Life Sciences Companies
    7/17/2019

    A preview of an October 2109 issue article that discusses the results of the 2018 MassNextGen initiative that provides funding and coaching support to early-stage life sciences companies started by females.

  4. Robert Hariri’s Accidental Entry Into Filmmaking
    7/15/2019

    Robert Hariri, M.D., Ph.D., CEO of Celularity Therapeutics, shares how a biopharmaceutical industry CEO has come to know Hollywood celebrities.

  5. How LifeBankUSA Became A Life-Changing Investment
    7/8/2019

    Robert Hariri, M.D., Ph.D., CEO of Celularity, shares a story of an investor’s life being altered dramatically by an investment in one of his companies.

  6. Why Mutually Beneficial Partnerships Can Be Hard To Find For Startups
    6/17/2019

    Bassil Dahiyat, Ph.D., president and CEO of Xencor, shares his perspective on why full-time equivalent (FTE) partnering deals are money losers.

  7. 3 Valuable Lessons Learned By A First-Time Entrepreneur
    6/10/2019

    Bassil Dahiyat, Ph.D., president and CEO of Xencor, a publicly traded biotech he founded right out of graduate school, shares three formative experiences gained as a first-time entrepreneur.

  8. Why Orchard Therapeutics Mark Rothera Is A Rare Disease Champion
    5/20/2019

    The career path of Orchard Therapeutics’ CEO Mark Rothera provides insight into how the executive came to be a champion of rare disease drug development.

  9. How Mark Rothera Came To His Dream Job
    5/13/2019

    Mark Rothera spent the majority of his career working for U.S.-based biopharmas. So, when he had the opportunity to work in his home country and preferred therapeutic area, he pursued it relentlessly.

  10. 6 Things You Might Not Know About Richard Pops, CEO Of Alkermes
    4/22/2019

    You might know Richard Pops is one of the longest tenured CEOs in biopharma, but here are six things perhaps you didn’t know about the chairman of Alkermes.